Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 15 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

891 Pre-clinical development of a best-in-class bispecific T cell engager targeting a highly abundant peptide for the treatment of melanoma

  • Samuel Ward1
  • David Cook2
  • Xiaoyan Pan2
  • Simon Wright1
  • Dzmitry Batrakou2
  • Amalia Martinez2
  • Hemza Ghadbane2
  • Dominic Hine2
  • Peter Cain1
  • Eleanor Bagg2
  • Jana Rundle2
  • Juan Bolivar2
23 more authors
  • Maria Busz2
  • Samantha Drennan2
  • Sophie Wells2
  • Wilawan Bunjobpol2
  • Michela Marongiu2
  • Mathew Veal2
  • Samhita Rao2
  • Alexander Stephens1
  • Sophie Johnson1
  • Oleksandr Dudchenko1
  • Mark Lees2
  • Graham Ogg3
  • Sarah Leonard2
  • Jong Fu Wong4
  • Helena Horvatic4
  • Christos Gavriel4
  • Leonie Windeln4
  • Laura Chaffey4
  • Joanne Oates4
  • Mitchell P Levesque5
  • Thomas L Andresen4
  • Nathaniel J Davies4
  • Rebecca Ashfield4
5 affiliations
  1. 11T-Cypher Bio Ltd, Oxford, Oxfordshire, UK
  2. 21T-Cypher Bio, Oxford, Oxfordshire, UK
  3. 3MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK
  4. 4T-Cypher Bio, Oxford, Oxfordshire, UK
  5. 5Department of Dermatology, University of Zurich, University Hospital Zurich, Schlieren, Switzerland
Open at sourcePDFDOICite

Related

  1. Pre-clinical development of a novel CD3-CD123 bispecific T-cell engager using cross-over dual-variable domain (CODV) format for acute myeloid leukemia (AML) treatment.
    Bonnevaux H, Guerif S, Albrecht J +11
    OncoImmunologyPeer-reviewedCC BY-NCFull text16 citedMedical imaging & radiologyHAL
  2. From Dual Targeting to Clinical Validation: A Translational Framework for Bispecific Antibody–Drug Conjugates
    Jun Kim, Seounghun Kang
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textMedical imaging & radiologyCrossrefEurope PMC
  3. Bispecific antibodies targeting B‐cell maturation antigen in multiple myeloma: Current clinical applications, challenges and future directions
    Enrica Manzato, Gloria Cocchetto, Simona Barbato +3
    CancerPeer-reviewedCC BY 4.0Full textGeneral medicinePMC
  4. PF chemotherapy combined with a PD-1/CTLA-4 bispecific antibody as first-line treatment in patients with recurrent/metastatic head and neck squamous cell carcinoma: a prospective, single-arm, phase II clinical study
    Wenjun Liao, Qiaohua Li, Yue Deng +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  5. Heterocyclic scaffolds targeting IDO1: progress in medicinal chemistry and clinical development
    Ankush Kumar, Vishakha Sharma, Rajiv Patel +2
    Future Medicinal ChemistryPeer-reviewedLicence not statedFull textOncologyPMC

Cite

BibTeXRIS
BibTeX
@article{ward2026preclinical,
  title = {{891 Pre-clinical development of a best-in-class bispecific T cell engager targeting a highly abundant peptide for the treatment of melanoma}},
  author = {Samuel Ward and David Cook and Xiaoyan Pan and Simon Wright and Dzmitry Batrakou and Amalia Martinez and Hemza Ghadbane and Dominic Hine and Peter Cain and Eleanor Bagg and Jana Rundle and Juan Bolivar and Maria Busz and Samantha Drennan and Sophie Wells and Wilawan Bunjobpol and Michela Marongiu and Mathew Veal and Samhita Rao and Alexander Stephens and Sophie Johnson and Oleksandr Dudchenko and Mark Lees and Graham Ogg and Sarah Leonard and Jong Fu Wong and Helena Horvatic and Christos Gavriel and Leonie Windeln and Laura Chaffey and Joanne Oates and Mitchell P Levesque and Thomas L Andresen and Nathaniel J Davies and Rebecca Ashfield},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0891},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0891},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 891 Pre-clinical development of a best-in-class bispecific T cell engager targeting a highly abundant peptide for the treatment of melanoma
AU  - Samuel Ward
AU  - David Cook
AU  - Xiaoyan Pan
AU  - Simon Wright
AU  - Dzmitry Batrakou
AU  - Amalia Martinez
AU  - Hemza Ghadbane
AU  - Dominic Hine
AU  - Peter Cain
AU  - Eleanor Bagg
AU  - Jana Rundle
AU  - Juan Bolivar
AU  - Maria Busz
AU  - Samantha Drennan
AU  - Sophie Wells
AU  - Wilawan Bunjobpol
AU  - Michela Marongiu
AU  - Mathew Veal
AU  - Samhita Rao
AU  - Alexander Stephens
AU  - Sophie Johnson
AU  - Oleksandr Dudchenko
AU  - Mark Lees
AU  - Graham Ogg
AU  - Sarah Leonard
AU  - Jong Fu Wong
AU  - Helena Horvatic
AU  - Christos Gavriel
AU  - Leonie Windeln
AU  - Laura Chaffey
AU  - Joanne Oates
AU  - Mitchell P Levesque
AU  - Thomas L Andresen
AU  - Nathaniel J Davies
AU  - Rebecca Ashfield
PY  - 2026
DA  - 2026/11/07
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0891
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0891
SN  - 2051-1426
ER  -